Skip to content

Clinical trials

Phase 3 Influenza, Human trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Influenza, Human Phase: Phase 3 Country / region: France Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20063
20071
20082
20093
20104
20111
20121
20142
20161
20192
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline8
Sanofi Pasteur, a Sanofi Company5
Assistance Publique - Hôpitaux de Paris4
Hoffmann-La Roche3
AstraZeneca1
Centre Hospitalier Régional Metz-Thionville1
UMC Utrecht1
University of Versailles1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Influenza, Human24
Orthomyxoviridae Infections3
Respiratory Distress Syndrome3
COVID-192
Lung Diseases2
Respiratory Tract Diseases2
Respiratory Tract Infections2
Acute Lung Injury1
Communicable Diseases1
Community-Acquired Pneumonia1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.